Latest period
$163M
YoY change
-2.6%
5Y CAGR
+11.3%
Peak year (FY2024)
$162M
Latest annual
$158M
Stock-Based Compensation history chart for Edwards Lifesciences (EW) from 2016 to 2025
Latest: $158M
Stock-Based Compensation growth chart for Edwards Lifesciences (EW) from 2016 to 2025
Latest: -2.6%
Stock-Based Compensation history table for Edwards Lifesciences (EW) from 1999 to 2025
| FY2025 | $158M | -2.6% | -$4.2M | ||
| FY2024 | $162M | +16.4% | +$22.9M | ||
| FY2023 | $139M | +9.9% | +$12.6M | ||
| FY2022 | $127M | +16.0% | +$17.5M | ||
| FY2021 | $109M | +18.0% | +$16.7M | ||
| FY2020 | $92.6M | +13.9% | +$11.3M | ||
| FY2019 | $81.3M | +14.5% | +$10.3M | ||
| FY2018 | $71M | +15.3% | +$9.4M | ||
| FY2017 | $61.6M | +8.3% | +$4.7M | ||
| FY2016 | $56.9M | +14.0% | +$7M | ||
| FY2015 | $49.9M | +3.3% | +$1.6M | ||
| FY2014 | $48.3M | +1.9% | +$900K | ||
| FY2013 | $47.4M | +12.6% | +$5.3M | ||
| FY2012 | $42.1M | +20.3% | +$7.1M | ||
| FY2011 | $35M | +19.5% | +$5.7M | ||
| FY2010 | $29.3M | +3.5% | +$1M | ||
| FY2009 | $28.3M | -1.4% | -$400K | ||
| FY2008 | $28.7M | +3.6% | +$1M | ||
| FY2007 | $27.7M | +4.1% | +$1.1M | ||
| FY2006 | $26.6M | — | +$26.6M | ||
| FY2005 | $0.00 | — | $0.00 | ||
| FY2004 | $0.00 | — | $0.00 | ||
| FY2003 | $0.00 | — | $0.00 | ||
| FY2002 | $0.00 | — | $0.00 | ||
| FY2001 | $0.00 | — | $0.00 | ||
| FY2000 | $0.00 | — | $0.00 | ||
| FY1999 | $0.00 | — | — |
- FY2025$158M-2.6%
- FY2024$162M+16.4%
- FY2023$139M+9.9%
- FY2022$127M+16.0%
- FY2021$109M+18.0%
- FY2020$92.6M+13.9%
- FY2019$81.3M+14.5%
- FY2018$71M+15.3%
- FY2017$61.6M+8.3%
- FY2016$56.9M+14.0%
- FY2015$49.9M+3.3%
- FY2014$48.3M+1.9%
- FY2013$47.4M+12.6%
- FY2012$42.1M+20.3%
- FY2011$35M+19.5%
- FY2010$29.3M+3.5%
- FY2009$28.3M-1.4%
- FY2008$28.7M+3.6%
- FY2007$27.7M+4.1%
- FY2006$26.6M—
- FY2005$0.00—
- FY2004$0.00—
- FY2003$0.00—
- FY2002$0.00—
- FY2001$0.00—
- FY2000$0.00—
- FY1999$0.00—
Stock-Based Compensation values are taken from Edwards Lifesciences's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Edwards Lifesciences (EW)
Stock-Based Compensation for Edwards Lifesciences (EW): headline value $163M · YoY -2.6%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Edwards Lifesciences (EW) stock-based compensation is $158M – edged down 2.6% year-over-year.
Edwards Lifesciences stock-based compensation compound annual growth for the 2020–2025 (5 years) window is +11.3%, with mixed annual results across the window.
The highest annual stock-based compensation of $162M was reported in 2024. The lowest in the available history was $0.00 in 1999.
Edwards Lifesciences Stock-Based Compensation by Year
Edwards Lifesciences Stock-Based Compensation 2025: $158M
In 2025, Edwards Lifesciences reported stock-based compensation of $158M, edged down 2.6% below 2024.
Edwards Lifesciences Stock-Based Compensation 2024: $162M
Edwards Lifesciences stock-based compensation in 2024 was $162M, grew 16.4% from 2023. This figure represents the highest annual value in the available history.
Edwards Lifesciences Stock-Based Compensation 2023: $139M
2023's stock-based compensation for Edwards Lifesciences came in at $139M, grew 9.9% from 2022.
Edwards Lifesciences Stock-Based Compensation 2022: $127M
Edwards Lifesciences posted stock-based compensation of $127M in 2022, grew 16.0% from 2021.
Edwards Lifesciences Stock-Based Compensation 2021: $109M
Edwards Lifesciences stock-based compensation in 2021 was $109M.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Stock-Based Compensation
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest stock-based compensation
| $1.35B | |
| $971M | |
| $955M | |
| $626M | |
| $494M | |
| $310M | |
| $0.00 | |
| $0.00 |
- $1.35B
- $955M
- $626M
- $494M
- $0.00
- $0.00
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.